Longitudinal observation of insulin secretory ability before and after the onset of immune checkpoint inhibitor-induced diabetes mellitus: A report of two cases.

Noriko FujiwaraMayu Watanabe Akihiro KatayamaYohei NodaJun EguchiHitomi KataokaShunsuke KagawaJun Wada

Published in: Clinical case reports (2021)

Immune checkpoint inhibitor-induced diabetes mellitus is a rare immune-related adverse event. This report illustrates clinical data and insulin secretory ability before and after the onset of immune checkpoint inhibitor-induced diabetes.

Keyphrases

type diabetes
glycemic control
high glucose
diabetic rats
drug induced
emergency department
endothelial cells
cross sectional
electronic health record
big data
skeletal muscle